Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GC10628 structure
    GC10628nor-NOHA (acetate)
    CAS: 1140844-63-8
    纯度: >97.00% / >98.00%

    nor-NOHA(醋酸盐)(α-氨基酸 N(omega) -Hydroxy-Nor-L-arginine)是一种有效且可逆的选择性精氨酸酶抑制剂,nor-NOHA(醋酸盐)的效力大约是 40 倍NOHA 抑制未受刺激的小鼠巨噬细胞催化 l-精氨酸水解为 l-鸟氨酸(nor-NOHA IC(50) 值 12 77777#177;5µM。

  • GC10638 structure
    GC10638AT9283
    CAS: 896466-04-9
    纯度: >99.50%

    A broad spectrum kinase inhibitor

  • GC10647 structure
    GC10647FR 180204
    CAS: 865362-74-9
    纯度: >98.00%

    FR 180204是一种选择性的ERK抑制剂,对ERK1和ERK2的IC 50 值分别为0.51μM和0.33μM。

  • GC10661 structure
    GC10661Destruxin B
    CAS: 2503-26-6

    An insecticidal mycotoxin

  • GC10662 structure
    GC10662WYE-354
    CAS: 1062169-56-5
    纯度: >98.00%

    Potent inhibitor of mTOR in both mTORC1 and mTORC2

  • GC10666 structure
    GC10666CGP 57380
    CAS: 522629-08-9
    纯度: >98.00%

    Inhibitor of MAPK-interacting kinase1

  • GC10686 structure
    GC10686Epirubicin HCl
    CAS: 56390-09-1
    纯度: >99.00% / >99.50%

    Epirubicin HCl是一种具有口服活性的DNA topoisomerase II特异性抑制剂,IC 50 为12μM。

  • GC10692 structure
    GC10692Caffeic Acid Phenethyl Ester
    CAS: 104594-70-9
    纯度: >98.00%

    Caffeic Acid Phenethyl Ester是一种天然存在蜂胶中的苯丙素类化合物,具有多种生物学活性。

  • GC10721 structure
    GC10721BDA-366
    CAS: 1909226-00-1

    A Bcl2-BH4 domain antagonist

  • GC10734 structure
    GC10734β-Lapachone
    CAS: 4707-32-8
    纯度: >99.50% / >98.00%

    β-Lapachone是一种邻萘醌天然产物,具有抗炎、抗菌及抗锥虫等多种生物活性,且能抑制拓扑异构酶I并诱导NAD(P)H:醌氧化还原酶1。

  • GC10744 structure
    GC10744Bendamustine HCl
    CAS: 3543-75-7
    纯度: >98.50%

    A DNA alkylating agent

  • GC10801 structure
    GC10801Disulfiram
    CAS: 97-77-8
    纯度: >99.50%

    An irreversible inhibitor of aldehyde dehydrogenase

  • GC10809 structure
    GC10809LRRK2-IN-1
    CAS: 1234480-84-2
    纯度: >99.00%

    A selective LRRK2 inhibitor

  • GC10813 structure
    GC10813Clofibric Acid
    CAS: 882-09-7
    纯度: >99.50%

    A PPARα agonist and the active metabolite of clofibrate

  • GC10816 structure
    GC10816GDC-0941
    CAS: 957054-30-7
    纯度: ≥98%

    GDC-0941是一种口服有效的I类PI3K泛抑制剂,对p110α、p110β、p110δ和p110γ的IC 50 值分别为3nM、33nM、3nM和75nM。

  • GC10820 structure
    GC10820Rottlerin
    CAS: 82-08-6
    纯度: >98.00%

    Rottlerin 是从 Mallotus Philippinensis 中纯化得到的天然产物,是一种特异性蛋白激酶C(PKC)抑制剂,对PKCδ的 IC 50 值为3-6μM,对PKCα、β、γ 的IC 50 值为30-42μM,对PKCε、η、ζ 的IC 50 值为 80-100μM。

  • GC10824 structure
    GC10824DBeQ
    CAS: 177355-84-9
    纯度: >99.50%

    A selective inhibitor of the ATPase p97

  • GC10839 structure
    GC10839Tubastatin A
    CAS: 1252003-15-8
    纯度: >98.00%

    Tubastatin A 是一种有效的选择性 HDAC6 抑制剂,IC 50 值为 15 nM。并且Tubastatin A也是一种新型GPX4抑制剂,Tubastatin A 直接与 GPX4 结合,诱导乳腺癌细胞铁死亡。

  • GC10855 structure
    GC10855Etretinate
    CAS: 54350-48-0
    纯度: >98.00%

    A second-generation retinoid

  • GC10893 structure
    GC10893Dutasteride
    CAS: 164656-23-9
    纯度: >99.50%

    An inhibitor of steroid 5α-reductase

  • GC10944 structure
    GC10944Butein
    CAS: 487-52-5
    纯度: >98.00%

    A plant polyphenol

  • GC10951 structure
    GC10951Ac-DEVD-CMK
    CAS: 285570-60-7

    An inhibitor of caspase-3

  • GC10970 structure
    GC10970WP1130
    CAS: 856243-80-6
    纯度: >99.50%

    A deubiquitinase inhibitor

  • GC10978 structure
    GC10978Terfenadine
    CAS: 50679-08-8
    纯度: >98.00%

    A selective histamine H 1 -receptor antagonist